Highlights and Quick Summary
- Consolidated Net Income/Loss for the quarter ending December 31, 2022 was $-5.41 Million (a 6.24% increase compared to previous quarter)
- Year-over-year quarterly Consolidated Net Income/Loss increased by 65.22%
- Annual Consolidated Net Income/Loss for 2022 was $-18.2 Million (a -0.0% decrease from previous year)
- Annual Consolidated Net Income/Loss for 2022 was $-18.2 Million (a 31.16% increase from previous year)
- Annual Consolidated Net Income/Loss for 2021 was $-13.9 Million (a -0.0% decrease from previous year)
- Twelve month Consolidated Net Income/Loss ending December 31, 2022 was $-18.8 Million (a 3.23% increase compared to previous quarter)
- Twelve month trailing Consolidated Net Income/Loss increased by 9.93% year-over-year
Trailing Consolidated Net Income/Loss for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| $-18.8 Million | $-18.3 Million | $-18.2 Million | $-17.1 Million |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Consolidated Net Income/Loss of Benitec Biopharma Limited
Most recent Consolidated Net Income/Lossof BNTC including historical data for past 10 years.Interactive Chart of Consolidated Net Income/Loss of Benitec Biopharma Limited
Benitec Biopharma Limited Consolidated Net Income/Loss for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $-5.41 | $-5.09 | $-5.07 | $-3.28 | $-18.21 |
| 2021 | $-4.82 | $-5.05 | $-4.0 | $-3.91 | $-13.88 |
| 2020 | $-3.25 | $-2.72 | $-2.94 | $-2.1 | $-8.27 |
| 2019 | – | – | $-2.09 | $-1.15 | $2.61 |
| 2018 | – | – | – | – | $-9.02 |
| 2017 | – | – | – | $-2.27 | $-4.29 |
| 2016 | – | – | – | $0.56 | $-18.05 |
| 2015 | – | – | – | – | $-9.64 |
| 2014 | – | – | – | – | $-6.46 |
| 2013 | – | – | – | – | $-3.58 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology